Literature DB >> 11123053

Non-HIV retroviral associations with rheumatic disease.

D Zucker-Franklin1.   

Abstract

While the human T-cell lymphotropic virus type I (HTLV-I) is the recognized cause of adult T cell leukemia, it is also associated with non-neoplastic, ostensibly autoimmune conditions, such as tropical spastic paraparesis. Moreover,among carriers of HTLV-I, the virus is strongly implicated in the development of a type of arthritis, which resembles rheumatoid arthritis (RA). Mice transgenic for HTLV-I tax develop RA-like pathology and Sjögren's syndrome. Patients with RA and SS in HTLV-I nonendemic regions, such as the United States, are usually serologically negative for antibodies to the structural proteins of HTLV. However, they appear to harbor HTLV-I tax in their peripheral blood mononuclear cells three times as often as individuals who present as healthy blood donors. Because HTLV-I tax transactivates numerous inflammatory cytokines and is not normally found in the human genome, treatment with tax antisense oligonucleotides may provide a new therapeutic approach for selected RA patients proven to be HTLV-I "tax only" positive.

Entities:  

Mesh:

Year:  2000        PMID: 11123053     DOI: 10.1007/s11926-000-0056-0

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  66 in total

1.  Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice.

Authors:  J E Green; S H Hinrichs; J Vogel; G Jay
Journal:  Nature       Date:  1989-09-07       Impact factor: 49.962

2.  Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

Authors:  L W Moreland; M H Schiff; S W Baumgartner; E A Tindall; R M Fleischmann; K J Bulpitt; A L Weaver; E C Keystone; D E Furst; P J Mease; E M Ruderman; D A Horwitz; D G Arkfeld; L Garrison; D J Burge; C M Blosch; M L Lange; N D McDonnell; M E Weinblatt
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

3.  Abnormal B-cell function in HTLV-I-tax transgenic mice.

Authors:  R S Peebles; C R Maliszewski; T A Sato; J Hanley-Hyde; I G Maroulakou; R Hunziker; J P Schneck; J E Green
Journal:  Oncogene       Date:  1995-03-16       Impact factor: 9.867

4.  Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome.

Authors:  K Terada; S Katamine; K Eguchi; R Moriuchi; M Kita; H Shimada; I Yamashita; K Iwata; Y Tsuji; S Nagataki
Journal:  Lancet       Date:  1994-10-22       Impact factor: 79.321

5.  Extracellular Tax1 protein stimulates tumor necrosis factor-beta and immunoglobulin kappa light chain expression in lymphoid cells.

Authors:  P F Lindholm; R L Reid; J N Brady
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

6.  High frequencies of identical T cell clonotypes in synovial tissues of rheumatoid arthritis patients suggest the occurrence of common antigen-driven immune responses.

Authors:  Y Ikeda; K Masuko; Y Nakai; T Kato; T Hasanuma; S I Yoshino; Y Mizushima; K Nishioka; K Yamamoto
Journal:  Arthritis Rheum       Date:  1996-03

7.  Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-kappa B.

Authors:  I Kitajima; T Shinohara; J Bilakovics; D A Brown; X Xu; M Nerenberg
Journal:  Science       Date:  1992-12-11       Impact factor: 47.728

8.  Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors.

Authors:  A E Williams; C T Fang; D J Slamon; B J Poiesz; S G Sandler; W F Darr; G Shulman; E I McGowan; D K Douglas; R J Bowman
Journal:  Science       Date:  1988-04-29       Impact factor: 47.728

9.  Repeat array in Epstein-Barr virus DNA is related to cell DNA sequences interspersed on human chromosomes.

Authors:  M Heller; A Henderson; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

10.  Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody.

Authors:  G Horneff; G R Burmester; F Emmrich; J R Kalden
Journal:  Arthritis Rheum       Date:  1991-02
View more
  5 in total

Review 1.  Studying Sjögren's syndrome in mice: What is the best available model?

Authors:  Ghada Abughanam; Ola M Maria; Simon D Tran
Journal:  J Oral Biol Craniofac Res       Date:  2020-12-08

Review 2.  Treatment of HTLV-I-associated myelopathy/tropical spastic paraparesis: toward rational targeted therapy.

Authors:  Unsong Oh; Steven Jacobson
Journal:  Neurol Clin       Date:  2008-08       Impact factor: 3.806

3.  Establishment of hybridomas producing cancer specific human antibodies from B cell line derived from PBL of a patient with adult T cell leukemia.

Authors:  T Kawahara; A Ichikawa; Y Katakura; K Teruya; T Yoshida; M Kikuchi; M Kamei; S Hashizume; S Shirahata
Journal:  Cytotechnology       Date:  2001-07       Impact factor: 2.058

Review 4.  Current concepts: mouse models of Sjögren's syndrome.

Authors:  Tegan N Lavoie; Byung Ha Lee; Cuong Q Nguyen
Journal:  J Biomed Biotechnol       Date:  2010-12-30

5.  Altered expression of inflammatory cytokines in primary osteoarthritis by human T lymphotropic virus type I retrovirus infection: a cross-sectional study.

Authors:  Yoshiki Yoshihara; Tomoo Tsukazaki; Makoto Osaki; Masahiro Nakashima; Kazuhisa Hasui; Hiroyuki Shindo
Journal:  Arthritis Res Ther       Date:  2004-06-07       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.